Harmony Biosciences Holdings, Inc. (HRMY)
32.47
-1.94
(-5.65%)
USD |
NASDAQ |
Nov 05, 16:00
32.15
-0.32
(-0.99%)
After-Hours: 05:18
Harmony Biosciences Holdings SG&A Expense (TTM) : 213.11M for Sept. 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 213.11M |
| June 30, 2026 | 272.47M |
| March 31, 2026 | 274.30M |
| December 31, 2025 | 272.05M |
| September 30, 2025 | 241.77M |
| June 30, 2025 | 238.58M |
| March 31, 2025 | 230.31M |
| December 31, 2024 | 221.27M |
| September 30, 2024 | 219.56M |
| June 30, 2024 | 209.36M |
| March 31, 2024 | 200.97M |
| December 31, 2023 | 192.69M |
| September 30, 2023 | 181.65M |
| June 30, 2023 | 177.49M |
| March 31, 2023 | 172.47M |
| December 31, 2022 | 163.30M |
| Date | Value |
|---|---|
| September 30, 2022 | 156.90M |
| June 30, 2022 | 148.44M |
| March 31, 2022 | 137.44M |
| December 31, 2021 | 132.03M |
| September 30, 2021 | 125.71M |
| June 30, 2021 | 115.48M |
| March 31, 2021 | 103.08M |
| December 31, 2020 | 95.57M |
| September 30, 2020 | 64.58M |
| June 30, 2020 | 41.47M |
| March 31, 2020 | 36.81M |
| December 31, 2019 | 24.42M |
| September 30, 2019 | 24.42M |
| June 30, 2019 | 24.42M |
| March 31, 2019 | 10.15M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Liquidia Corp. | 192.66M |
| Pfizer Inc. | 10.53B |
| Bristol Myers Squibb Co. | 7.323B |
| Repligen Corp. | 311.11M |
| ANI Pharmaceuticals, Inc. | 324.76M |